Advertisement
Screener

ENANTA PHARMACEUTICALS, INC (ENTA) Payments for (Proceeds from) Other Investing Activities

1.6 / 5 stars · 38/120 Roast Me

ENANTA PHARMACEUTICALS, INC Payments for (Proceeds from) Other Investing Activities

ENANTA PHARMACEUTICALS, INC (ENTA) reported Payments for (Proceeds from) Other Investing Activities of $163.00 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2017-12-11.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2017-12-11

  • ENANTA PHARMACEUTICALS, INC payments for (proceeds from) other investing activities for fiscal 2015 was $163.00K.
  • ENANTA PHARMACEUTICALS, INC payments for (proceeds from) other investing activities for fiscal 2014 was -$3.00K.
Period endPayments for (Proceeds from) Other Investing Activities 12 month
2015-09-30$163.00K
10-K · filed 2017-12-11
2014-09-30-$3.00K
10-K · filed 2016-12-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Rezolute, Inc. (RZLT)United States$0.382B-6.45
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63